Findings point to the CXCR4/CXCL12 axis and cellular stress pathways as candidate therapeutic targets, though as a single-case observation this remains preliminary and requires validation in larger cohorts, at the protein level, and in functional in vitro/in vivo studies.
Abstract
Thyroid eye disease (TED) is an autoimmune inflammatory disorder of the orbit closely associated with thyroid dysfunction. Total thyroidectomy is traditionally expected to attenuate the autoimmune cascade, yet some patients continue to progress after surgery, which challenges this paradigm and points to a potentially autonomous orbital immune response. To investigate this, we performed single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) from a 47-year-old woman with severe, glucocorticoid-refractory TED, four years after total thyroidectomy, and compared her immune landscape with that of an age- and sex-matched healthy control. The patient’s peripheral blood showed a clear shift toward an active, stress-associated inflammatory state: pro-inflammatory mediators, immediate-early response transcription factors (FOS, JUNB, FOSB, TNFAIP3), and survival-related genes (CXCR4, DDIT4) were all upregulated. Gene Set Enrichment Analysis (GSEA) pointed to different mechanisms across cell types—myeloid cells were enriched for IL-6/JAK/STAT3 and TNF-α signaling, activated T cells for oxidative phosphorylation and mTORC1 signaling—while B lymphocytes and NK cells showed the opposite pattern, with reduced inflammatory and metabolic activity. One possible explanation is a “tissue-drainage” effect, where the most pathogenic lymphocytes leave the bloodstream and migrate into the inflamed orbital tissue along chemokine gradients. Together, these findings point to the CXCR4/CXCL12 axis and cellular stress pathways as candidate therapeutic targets, though as a single-case observation this remains preliminary and requires validation in larger cohorts, at the protein level, and in functional in vitro/in vivo studies.
Summary Around 20% of patients with rheumatoid arthritis (RA) have disease that remains refractory to multiple targeted treatments, highlighting a major clinical challenge. We determine single-nucleus transcriptional and chromatin landscapes (10x Genomics Epi Multiome) on 14,625 primary CD4+ T-cells isolated from treat...
S. Smith, Stefano Rossi, R. Shukla et al.· iScience· 0 citations
Functional enrichment analysis showed that the co-stimulation, cytotoxicity, antigen processing and presentation, and inflammation promotion of various immune cells in PMR patients were all enhanced.
T. Cai, Q. Qin, Yan-Fei Jiang et al.· Frontiers in Immunology· 0 citations
Abstract SMN-enhancing therapies have improved outcomes in adult late-onset spinal muscular atrophy (loSMA), but minimally invasive biomarkers that reflect systemic disease and treatment effects are lacking. In this retrospective cohort study, we profiled circulating cell-free messenger RNA (ccfmRNA) in serum samples f...
M. Leo, Linda-Isabell Schmitt, K. C. Liebig et al.· Brain Communications· 0 citations
Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, but despite therapeutic advances, relapse remains a major challenge. Identifying biomarkers that reflect disease status and prognosis may help improve disease assessment and patient management. This study investigated the expression and cli...
Akram Sadat Jaafarian, S. Ahmadi, Mohammad Faranoush et al.· Scientific Reports· 0 citations
BACKGROUND
Thyroid carcinoma (THCA) represents the most prevalent malignancy of the endocrine system. Although the majority of patients exhibit favorable clinical outcomes, a subset still faces significant clinical challenges, including distant metastasis, recurrence, and poor response to therapeutic interventions, all...
Liang Chen, Chao-Hon Fu, Yang Chen et al.· Advances in Clinical and Exp...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.